0001209191-21-066257.txt : 20211122
0001209191-21-066257.hdr.sgml : 20211122
20211122202217
ACCESSION NUMBER: 0001209191-21-066257
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211118
FILED AS OF DATE: 20211122
DATE AS OF CHANGE: 20211122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEVIN ARTHUR A
CENTRAL INDEX KEY: 0001181556
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39321
FILM NUMBER: 211434369
MAIL ADDRESS:
STREET 1: 1896 RUTHERFORD ROAD
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Avidity Biosciences, Inc.
CENTRAL INDEX KEY: 0001599901
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461336960
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-401-7900
MAIL ADDRESS:
STREET 1: 10975 N. TORREY PINES RD.,
STREET 2: #150
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity Biosciences LLC
DATE OF NAME CHANGE: 20161227
FORMER COMPANY:
FORMER CONFORMED NAME: Avidity NanoMedicines LLC
DATE OF NAME CHANGE: 20140211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-11-18
0
0001599901
Avidity Biosciences, Inc.
RNA
0001181556
LEVIN ARTHUR A
C/O AVIDITY BIOSCIENCES, INC.
10975 N. TORREY PINES RD., SUITE 150
LA JOLLA
CA
92037
0
1
0
0
Chief Scientific Officer
Common Stock
2021-11-18
4
M
0
24396
1.24
A
25726
D
Common Stock
2021-11-18
4
M
0
604
0.53
A
26330
D
Common Stock
2021-11-18
4
S
0
25000
27.8887
D
1330
D
Stock Option (Right to Buy)
1.24
2021-11-18
4
M
0
24396
0.00
D
2030-02-18
Common Stock
24396
166770
D
Stock Option (Right to Buy)
0.53
2021-11-18
4
M
0
604
0.00
D
2027-08-28
Common Stock
604
41743
D
The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.2150.The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
25% of the shares subject to the option vested on February 19, 2021, and 1/48th of the shares subject to the option will vest monthly thereafter.
This option is exercisable as to vested and unvested shares. The option was granted on August 29, 2017 and 1/48th of the shares subject to the option vest monthly.
/s/ John W. Wallen III, Ph.D., J.D., Attorney-in-Fact
2021-11-22